These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 22641309)

  • 1. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
    Chalasani N; Younossi Z; Lavine JE; Diehl AM; Brunt EM; Cusi K; Charlton M; Sanyal AJ; ; ;
    Am J Gastroenterol; 2012 Jun; 107(6):811-26. PubMed ID: 22641309
    [No Abstract]   [Full Text] [Related]  

  • 2. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
    Chalasani N; Younossi Z; Lavine JE; Diehl AM; Brunt EM; Cusi K; Charlton M; Sanyal AJ
    Hepatology; 2012 Jun; 55(6):2005-23. PubMed ID: 22488764
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fatty liver: frequent and not completely harmless].
    Lang C; Georgi A; Gubler C
    Praxis (Bern 1994); 2013 Sep; 102(18):1089-101. PubMed ID: 24005067
    [No Abstract]   [Full Text] [Related]  

  • 4. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.
    Chalasani N; Younossi Z; Lavine JE; Diehl AM; Brunt EM; Cusi K; Charlton M; Sanyal AJ; ; ;
    Gastroenterology; 2012 Jun; 142(7):1592-609. PubMed ID: 22656328
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of alcoholic and non-alcoholic fatty liver].
    Stremmel W; Blechacz B; Herrmann T; Rost D; Mueller S
    Internist (Berl); 2001 Dec; 42(12):1641-2, 1645-50. PubMed ID: 11793603
    [No Abstract]   [Full Text] [Related]  

  • 6. Alcoholic and nonalcoholic forms of fatty liver disease.
    Forgione A; Miele L; Cefalo C; Gasbarrini G; Grieco A
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):83-100. PubMed ID: 17415346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revision and update on clinical practice guideline for liver cirrhosis.
    Suk KT; Baik SK; Yoon JH; Cheong JY; Paik YH; Lee CH; Kim YS; Lee JW; Kim DJ; Cho SW; Hwang SG; Sohn JH; Kim MY; Kim YB; Kim JG; Cho YK; Choi MS; Kim HJ; Lee HW; Kim SU; Kim JK; Choi JY; Jun DW; Tak WY; Lee BS; Jang BK; Chung WJ; Kim HS; Jang JY; Jeong SW; Kim SG; Kwon OS; Jung YK; Choe WH; Lee JS; Kim IH; Shim JJ; Cheon GJ; Bae SH; Seo YS; Choi DH; Jang SJ;
    Korean J Hepatol; 2012 Mar; 18(1):1-21. PubMed ID: 22511898
    [No Abstract]   [Full Text] [Related]  

  • 8. [Steatosis and non-alcoholic steatohepatitis].
    Marín-López ER; Marín-Rentería NM
    Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():96-7. PubMed ID: 24041073
    [No Abstract]   [Full Text] [Related]  

  • 9. [Non-alcoholic steatohepatitis - from NAFLD to MAFLD].
    Balmer ML; Dufour JF
    Ther Umsch; 2011 Apr; 68(4):183-8. PubMed ID: 21452138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Noninvasive diagnosis of fatty liver disease].
    Qu Y; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):155-7. PubMed ID: 20196962
    [No Abstract]   [Full Text] [Related]  

  • 11. Will non-invasive testing replace liver biopsy in the diagnosis and follow-up of non-alcoholic steatohepatitis (NASH)?
    Romero FP
    Rev Esp Enferm Dig; 2009 Aug; 101(8):521-7. PubMed ID: 19785490
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatty liver: how frequent is it and why?
    Bedogni G; Bellentani S
    Ann Hepatol; 2004; 3(2):63-5. PubMed ID: 15257248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.
    Korean Association for the Study of the Liver (KASL)
    Clin Mol Hepatol; 2013 Dec; 19(4):325-48. PubMed ID: 24459637
    [No Abstract]   [Full Text] [Related]  

  • 14. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
    Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Leandro G; Correale M; Tutino V; Misciagna G; Osella AR; Bonfiglio C; Giannelli G; Caruso MG;
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-alcoholic fatty liver--life of overindulgence with fatty liver].
    Füessl HS
    MMW Fortschr Med; 2005 Jun; 147(25):4-6, 8. PubMed ID: 16038330
    [No Abstract]   [Full Text] [Related]  

  • 16. [Non-alcoholic fatty liver disease and steatohepatitis].
    Pár G; Horváth G; Pár A
    Orv Hetil; 2013 Jul; 154(29):1124-34. PubMed ID: 23853345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H; Moschen A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature.
    Ong J; Younossi ZM
    Am J Gastroenterol; 2010 Mar; 105(3):621-3. PubMed ID: 20203643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease in children.
    Janczyk W; Socha P
    Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):297-300. PubMed ID: 22521558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From NAFLD in clinical practice to answers from guidelines.
    Nascimbeni F; Pais R; Bellentani S; Day CP; Ratziu V; Loria P; Lonardo A
    J Hepatol; 2013 Oct; 59(4):859-71. PubMed ID: 23751754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.